The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Abstract
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
Yao, J. C., Shah, M. H., Ito, T., Bohas, C. L., Wolin, E. M., Van Cutsem, E., Hobday, T. J., Okusaka, T., Capdevila, J., de Vries, E. G. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009290 · Cited by 2,876
Self-citationSunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Raymond, E., Dahan, L., Raoul, J.-L., Bang, Y.-J., Borbath, I., Lombard-Bohas, C., Valle, J., Metrakos, P., Smith, D., Vinik, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1003825 · Cited by 2,567
Self-citationRinke, A., Müller, H.-H., Schade-Brittinger, C., Klose, K.-J., Barth, P., Wied, M., Mayer, C., Aminossadati, B., Pape, U.-F., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,508
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Self-citationKwekkeboom, D. J., de Herder, W. W., Kam, B. L., van Eijck, C. H., van Essen, M., Kooij, P. P., Feelders, R. A., van Aken, M. O., & Krenning, E. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2553 · Cited by 1,456
Self-citationPavel, M. E., Hainsworth, J. D., Baudin, E., Peeters, M., Hörsch, D., Winkler, R. E., Klimovsky, J., Lebwohl, D., Jehl, V., Wolin, E. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61742-x · Cited by 1,058
Self-citationGabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., & Virgolini, I. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035667 · Cited by 1,010
Moertel, C. G., Lefkopoulo, M., Lipsitz, S., Hahn, R. G., & Klaassen, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260804 · Cited by 976
Halfdanarson, T. R., Rabe, K. G., Rubin, J., & Petersen, G. M. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn351 · Cited by 892
Moertel, C. G., Kvols, L. K., O'Connell, M. J., & Rubin, J. (1991) · Cancer · doi:10.1002/1097-0142(19910715)68:2<227::aid-cncr2820680202>3.0.co;2-i · Cited by 840
Sarmiento, J. M., Heywood, G., Rubin, J., Ilstrup, D. M., Nagorney, D. M., & Que, F. G. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00230-8 · Cited by 773
Strosberg, J. R., Fine, R. L., Choi, J., Nasir, A., Coppola, D., Chen, D., Helm, J., & Kvols, L. (2011) · Cancer · doi:10.1002/cncr.25425 · Cited by 766
Moertel, C. G., Hanley, J. A., & Johnson, L. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032101 · Cited by 659
Yao, J. C., Lombard-Bohas, C., Baudin, E., Kvols, L. K., Rougier, P., Ruszniewski, P., Hoosen, S., St. Peter, J., Haas, T., Lebwohl, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2669 · Cited by 647
Self-citationActivity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
Kulke, M. H., Lenz, H.-J., Meropol, N. J., Posey, J., Ryan, D. P., Picus, J., Bergsland, E., Stuart, K., Tye, L., Huang, X., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9020 · Cited by 623
Hepatic neuroendocrine metastases: does intervention alter outcomes?1
Chamberlain, R. S., Canes, D., Brown, K. T., Saltz, L., Jarnagin, W., Fong, Y., & Blumgart, L. H. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00222-2 · Cited by 622
Jensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Self-citationKouvaraki, M. A., Ajani, J. A., Hoff, P., Wolff, R., Evans, D. B., Lozano, R., & Yao, J. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.024 · Cited by 607
Öberg, K., Kvols, L., Caplin, M., Delle Fave, G., de Herder, W., Rindi, G., Ruszniewski, P., Woltering, E. A., & Wiedenmann, B. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh216 · Cited by 577
Self-citationPancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Missiaglia, E., Dalai, I., Barbi, S., Beghelli, S., Falconi, M., della Peruta, M., Piemonti, L., Capurso, G., Di Florio, A., delle Fave, G., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.5988 · Cited by 536
Faiss, S., Pape, U.-F., Böhmig, M., Dörffel, Y., Mansmann, U., Golder, W., Riecken, E. O., & Wiedenmann, B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.142 · Cited by 501
Self-citationBinderup, T., Knigge, U., Loft, A., Federspiel, B., & Kjaer, A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1759 · Cited by 489
Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors
Ekeblad, S., Sundin, A., Janson, E. T., Welin, S., Granberg, D., Kindmark, H., Dunder, K., Kozlovacki, G., Örlefors, H., Sigurd, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2053 · Cited by 473
Hepatic resection for metastatic neuroendocrine carcinomas
Que, F. G., Nagorney, D. M., Batts, K. P., Linz, L. J., & Kvols, L. K. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80107-x · Cited by 462
Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center
Janson, E. T., Holmberg, L., Stridsberg, M., Eriksson, B., Theodorsson, E., Wilander, E., & öberg, K. (1997) · Annals of Oncology · doi:10.1023/a:1008215730767 · Cited by 455
Self-citationTumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
Waldherr, C., Pless, M., Maëcke, H. R., Schumacher, T., Crazzolara, A., Nitzsche, E. U., Haldemann, A. R., & Mueller‐Brand, J. (2002) · PubMed · Cited by 445
Kennedy, A. S., Dezarn, W. A., McNeillie, P., Coldwell, D., Nutting, C., Carter, D., Murthy, R., Rose, S., Warner, R. R. P., Liu, D., et al. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31815e4557 · Cited by 424
Scarpa, A., Mantovani, W., Capelli, P., Beghelli, S., Boninsegna, L., Bettini, R., Panzuto, F., Pederzoli, P., Fave, G. D., & Falconi, M. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.58 · Cited by 422
Preoperative Portal Vein Embolization for Extended Hepatectomy
Hemming, A. W., Reed, A. I., Howard, R. J., Fujita, S., Hochwald, S. N., Caridi, J. G., Hawkins, I. F., & Vauthey, J.-N. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000065265.16728.c0 · Cited by 419
Garcia-Carbonero, R., Capdevila, J., Crespo-Herrero, G., Díaz-Pérez, J. A., Martínez del Prado, M. P., Alonso Orduña, V., Sevilla-García, I., Villabona-Artero, C., Beguiristain-Gómez, A., Llanos-Muñoz, M., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq022 · Cited by 419
Self-citationMODLIN, I. M., PAVEL, M., KIDD, M., & GUSTAFSSON, B. I. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04174.x · Cited by 410
Self-citationPape, U., Jann, H., Müller‐Nordhorn, J., Bockelbrink, A., Berndt, U., Willich, S. N., Koch, M., Röcken, C., Rindi, G., & Wiedenmann, B. (2008) · Cancer · doi:10.1002/cncr.23549 · Cited by 405
Self-citationPanzuto, F., Nasoni, S., Falconi, M., Corleto, V. D., Capurso, G., Cassetta, S., Di Fonzo, M., Tornatore, V., Milione, M., Angeletti, S., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01017 · Cited by 391
Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
Modlin, I. M., Gustafsson, B. I., Moss, S. F., Pavel, M., Tsolakis, A. V., & Kidd, M. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1006-3 · Cited by 387
Self-citationPrognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
Pape, U.-F., Berndt, U., Muller-Nordhorn, J., Bohmig, M., Roll, S., Koch, M., Willich, S. N., & Wiedenmann, B. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0017 · Cited by 384
Self-citationKulke, M. H., Hornick, J. L., Frauenhoffer, C., Hooshmand, S., Ryan, D. P., Enzinger, P. C., Meyerhardt, J. A., Clark, J. W., Stuart, K., Fuchs, C. S., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1476 · Cited by 381
Isolated Liver Metastases from Neuroendocrine Tumors: Does Resection Prolong Survival?
Chen, H., Hardacre, J. M., Uzar, A., Cameron, J. L., & Choti, M. A. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00099-4 · Cited by 371
Neuroendocrine Hepatic Metastases: Does Aggressive Management Improve Survival?
Touzios, J. G., Kiely, J. M., Pitt, S. C., Rilling, W. S., Quebbeman, E. J., Wilson, S. D., & Pitt, H. A. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000161981.58631.ab · Cited by 362
Ekeblad, S., Skogseid, B., Dunder, K., Öberg, K., & Eriksson, B. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0734 · Cited by 360
Sun, W., Lipsitz, S., Catalano, P., Mailliard, J. A., & Haller, D. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.616 · Cited by 357
Kwekkeboom, D. J., Krenning, E. P., Lebtahi, R., Komminoth, P., Kos-Kudła, B., de Herder, W. W., & Plöckinger, U. (2009) · Neuroendocrinology · doi:10.1159/000225951 · Cited by 349
Self-citationKlöppel, G., Couvelard, A., Perren, A., Komminoth, P., McNicol, A.-M., Nilsson, O., Scarpa, A., Scoazec, J.-Y., Wiedenmann, B., Papotti, M., et al. (2009) · Neuroendocrinology · doi:10.1159/000182196 · Cited by 343
Self-citationNeuroendocrine tumors metastatic to the liver: How to select patients for liver transplantation?
Mazzaferro, V., Pulvirenti, A., & Coppa, J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.004 · Cited by 334
Orlefors, H., Sundin, A., Garske, U., Juhlin, C., Oberg, K., Skogseid, B., Langstrom, B., Bergstrom, M., & Eriksson, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1938 · Cited by 329
90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide
Bushnell, D. L., O'Dorisio, T. M., O'Dorisio, M. S., Menda, Y., Hicks, R. J., Van Cutsem, E., Baulieu, J.-L., Borson-Chazot, F., Anthony, L., Benson, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8585 · Cited by 306
Steinmüller, T., Kianmanesh, R., Falconi, M., Scarpa, A., Taal, B., Kwekkeboom, D. J., Lopes, J. M., Perren, A., Nikou, G., Yao, J., et al. (2008) · Neuroendocrinology · doi:10.1159/000111037 · Cited by 296
Self-citationPawlik, T. M., Izzo, F., Cohen, D. S., Morris, J. S., & Curley, S. A. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.026 · Cited by 296
Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma
de Herder, W. W., Niederle, B., Scoazec, J.-Y., Pauwels, S., Klöppel, G., Falconi, M., Kwekkeboom, D. J., Öberg, K., Eriksson, B., Wiedenmann, B., et al. (2006) · Neuroendocrinology · doi:10.1159/000098010 · Cited by 295
Self-citationJann, H., Roll, S., Couvelard, A., Hentic, O., Pavel, M., Müller‐Nordhorn, J., Koch, M., Röcken, C., Rindi, G., Ruszniewski, P., et al. (2011) · Cancer · doi:10.1002/cncr.25855 · Cited by 289
Self-citationWelin, S., Sorbye, H., Sebjornsen, S., Knappskog, S., Busch, C., & Öberg, K. (2011) · Cancer · doi:10.1002/cncr.26124 · Cited by 288
Self-citationSundin, A., Vullierme, M.-P., Kaltsas, G., & Plöckinger, U. (2009) · Neuroendocrinology · doi:10.1159/000184855 · Cited by 287
Gastrinoma (Duodenal and Pancreatic)
Jensen, R. T., Niederle, B., Mitry, E., Ramage, J. K., Steinmüller, T., Lewington, V., Scarpa, A., Sundin, A., Perren, A., Gross, D., et al. (2006) · Neuroendocrinology · doi:10.1159/000098009 · Cited by 284
Self-citationRadioembolization with selective internal radiation microspheres for neuroendocrine liver metastases
King, J., Quinn, R., Glenn, D. M., Janssen, J., Tong, D., Liaw, W., & Morris, D. L. (2008) · Cancer · doi:10.1002/cncr.23685 · Cited by 284
Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study
Ahmed, A., Turner, G., King, B., Jones, L., Culliford, D., McCance, D., Ardill, J., Johnston, B. T., Poston, G., Rees, M., et al. (2009) · Endocrine-Related Cancer · doi:10.1677/erc-09-0042 · Cited by 274
LIVER TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE CARCINOMA: An Analysis of 103 Patients
Lehnert, T. (1998) · Transplantation · doi:10.1097/00007890-199811270-00007 · Cited by 268
Mazzaglia, P. J., Berber, E., Milas, M., & Siperstein, A. E. (2007) · Surgery · doi:10.1016/j.surg.2007.01.036 · Cited by 256
Eriksson, B., Klöppel, G., Krenning, E., Ahlman, H., Plöckinger, U., Wiedenmann, B., Arnold, R., Auernhammer, C., Körner, M., Rindi, G., et al. (2008) · Neuroendocrinology · doi:10.1159/000111034 · Cited by 254
Self-citationArnold, R., Rinke, A., Klose, K.-J., Müller, H.-H., Wied, M., Zamzow, K., Schmidt, C., Schade-Brittinger, C., Barth, P., Moll, R., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00481-7 · Cited by 254
Self-citationDetection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT
Prasad, V., Ambrosini, V., Hommann, M., Hoersch, D., Fanti, S., & Baum, R. P. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1205-y · Cited by 249
Bajetta, E., Catena, L., Procopio, G., De Dosso, S., Bichisao, E., Ferrari, L., Martinetti, A., Platania, M., Verzoni, E., Formisano, B., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0306-6 · Cited by 240
Koopmans, K. P., Neels, O. C., Kema, I. P., Elsinga, P. H., Sluiter, W. J., Vanghillewe, K., Brouwers, A. H., Jager, P. L., & de Vries, E. G. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1126 · Cited by 238
Elias, D., Lasser, P., Ducreux, M., Duvillard, P., Ouellet, J.-F., Dromain, C., Schlumberger, M., Pocard, M., Boige, V., Miquel, C., et al. (2003) · Surgery · doi:10.1067/msy.2003.114 · Cited by 237
Self-citationLaparoscopic Radiofrequency Ablation of Neuroendocrine Liver Metastases
Berber, E., Flesher, N., & Siperstein, A. E. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6629-5 · Cited by 236
Glycemic Control in Patients with Insulinoma Treated with Everolimus
Kulke, M. H., Bergsland, E. K., & Yao, J. C. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0806740 · Cited by 234
Rhee, T. K., Lewandowski, R. J., Liu, D. M., Mulcahy, M. F., Takahashi, G., Hansen, P. D., Benson, A. B., Kennedy, A. S., Omary, R. A., & Salem, R. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181728a45 · Cited by 233
Hepatic surgery for metastases from neuroendocrine tumors
Sarmiento, J. M., & Que, F. G. (2003) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00076-5 · Cited by 227
Bettini, R., Boninsegna, L., Mantovani, W., Capelli, P., Bassi, C., Pederzoli, P., Delle Fave, G. F., Panzuto, F., Scarpa, A., & Falconi, M. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm552 · Cited by 213
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
Turner, N. C., Strauss, S. J., Sarker, D., Gillmore, R., Kirkwood, A., Hackshaw, A., Papadopoulou, A., Bell, J., Kayani, I., Toumpanakis, C., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605618 · Cited by 195
Arnold, R., Wilke, A., Rinke, A., Mayer, C., Kann, P. H., Klose, K., Scherag, A., Hahmann, M., Müller, H., & Barth, P. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.052 · Cited by 192
Le Treut, Y. P., Grégoire, E., Belghiti, J., Boillot, O., Soubrane, O., Mantion, G., Cherqui, D., Castaing, D., Ruszniewski, P., Wolf, P., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02233.x · Cited by 189
Interferon in the Management of Neuroendocrine GEP-Tumors
Öberg, K. (2000) · Digestion · doi:10.1159/000051862 · Cited by 187
Self-citationVogl, T. J., Naguib, N. N. N., Zangos, S., Eichler, K., Hedayati, A., & Nour-Eldin, N.-E. A. (2009) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.08.008 · Cited by 180
La Rosa, S., Klersy, C., Uccella, S., Dainese, L., Albarello, L., Sonzogni, A., Doglioni, C., Capella, C., & Solcia, E. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.06.005 · Cited by 174
The small remnant liver after major liver resection: How common and how relevant?
Yigitler, C., Farges, O., Kianmanesh, R., Regimbeau, J.-M., Abdalla, E. K., & Belghiti, J. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50194 · Cited by 174
Surgery on neuroendocrine tumours
Åkerström, G., & Hellman, P. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.12.004 · Cited by 172
Transcatheter chemoembolization of progressive carcinoid liver metastasis.
Therasse, E., Breittmayer, F., Roche, A., De Baere, T., Indushekar, S., Ducreux, M., Lasser, P., Elias, D., & Rougier, P. (1993) · Radiology · doi:10.1148/radiology.189.2.7692465 · Cited by 172
Islet 1 (Isl1) Expression is a Reliable Marker for Pancreatic Endocrine Tumors and Their Metastases
Schmitt, A. M., Riniker, F., Anlauf, M., Schmid, S., Soltermann, A., Moch, H., Heitz, P. U., Klöppel, G., Komminoth, P., & Perren, A. A. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318158a397 · Cited by 159
Self-citationPeptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
Kwekkeboom, D. J., de Herder, W. W., van Eijck, C. H. J., Kam, B. L. R., van Essen, M., Teunissen, J. J. M., & Krenning, E. P. (2010) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2009.10.004 · Cited by 156
Self-citationJain, R., Fischer, S. E., Serra, S., & Chetty, R. (2009) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e3181ad36ea · Cited by 153
Survival and Prognostic Factor Analysis of 146 Metastatic Neuroendocrine Tumors of the Mid-Gut
Strosberg, J., Gardner, N. M., & Kvols, L. K. (2009) · Neuroendocrinology · doi:10.1159/000197899 · Cited by 151
Kress, O., Wagner, H., Wied, M., Klose, K.-J., Arnold, R., & Alfke, H. (2003) · Digestion · doi:10.1159/000074522 · Cited by 150
Saxena, A., Chua, T. C., Bester, L., Kokandi, A., & Morris, D. L. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181d3d24a · Cited by 148
Elias, D. M., Baton, O., Sidéris, L., Boige, V., Malka, D., Liberale, G., Pocard, M. D., & Lasser, P. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20237 · Cited by 137
Rare Functioning Pancreatic Endocrine Tumors
O’Toole, D., Salazar, R., Falconi, M., Kaltsas, G., Couvelard, A., de Herder, W. W., Hyrdel, R., Nikou, G. C., Krenning, E. P., Vullierme, M., et al. (2006) · Neuroendocrinology · doi:10.1159/000098011 · Cited by 136
Self-citationDelaunoit, T., Ducreux, M. P., Boige, V., Dromain, C., Sabourin, J., Duvillard, P., Schlumberger, M. J., de Baère, T., Rougier, P. R., Ruffiè, P., et al. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.09.035 · Cited by 135
Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Perry, L. J., Stuart, K. E., Stokes, K. R., & Clouse, M. E. (1994) · PubMed · Cited by 135
Liver transplantation for neuroendocrine tumors
Florman, S. S., Toure, B., Kim, L., Gondolesi, G. E., Roayaie, S., Nancy, K., Fishbein, T., Emre, S., Miller, C. C., & Schwartz, M. E. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2003.11.010 · Cited by 134
Trends and Experiences in Liver Retransplantation Over 15 Years
Pfitzmann, R., Benscheidt, B., Langrehr, J. M., Schumacher, G., Neuhaus, R., & Neuhaus, P. (2007) · Liver Transplantation · doi:10.1002/lt.20904 · Cited by 133
Welin, S., Janson, E., Sundin, A., Stridsberg, M., Lavenius, E., Granberg, D. O., Skogseid, B. M., Öberg, K., & Eriksson, B. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510107 · Cited by 133
Self-citationHereditary neuroendocrine tumors of the gastroenteropancreatic system
Anlauf, M., Garbrecht, N., Bauersfeld, J., Schmitt, A. M., Henopp, T., Komminoth, P., Heitz, P. U., Perren, A. A., & Klöppel, G. (2007) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-007-0450-3 · Cited by 128
Self-citationEriksson, J., Stalberg, P. L. H., Nilsson, A., Krause, J., Lundberg, C. E., Skogseid, B. M., Granberg, D. O., Eriksson, B. K., Åkerström, G., & Hellman, P. (2008) · World Journal of Surgery · doi:10.1007/s00268-008-9510-3 · Cited by 113
Kann, P. H., Balakina, E., Ivan, D., Bartsch, D. K., Meyer, S., Klose, K., Behr, T., & Langer, P. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01220 · Cited by 106
Marrache, F., Vullierme, M., Roy, C., Assoued, Y. E., Couvelard, A., O’Toole, D., Mitry, E., Hentic, O., Hammel, P. R., Lévy, P., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603526 · Cited by 103
Self-citationButturini, G., Bettini, R., Missiaglia, E., Mantovani, W., Dalai, I., Capelli, P., Ferdeghini, M., Pederzoli, P., Scarpa, A., & Falconi, M. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01200 · Cited by 98
68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol
Ruf, J., Schiefer, J., Furth, C., Kosiek, O., Kropf, S., Heuck, F., Denecke, T., Pavel, M., Pascher, A., Wiedenmann, B., et al. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.083741 · Cited by 97
Self-citationIndications and Results of Liver Transplantation in Patients with Neuroendocrine Tumors
Olausson, M., Friman, S., Cahlin, C., Nilsson, O., Jansson, S. K. G., Wängberg, B., & Ahlman, H. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6631-y · Cited by 93
Bernheim, A. M., Connolly, H. M., Hobday, T. J., Abel, M., & Pellikka, P. A. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.12.002 · Cited by 93
Treatment with 90Y- and 177Lu-DOTATOC in patients with metastatic neuroendocrine tumors
Frilling, A., Weber, F., Saner, F. H., Bockisch, A., Hofmann, M., Mueller‐Brand, J., & Broelsch, C. E. (2006) · Surgery · doi:10.1016/j.surg.2006.07.030 · Cited by 90
Dahan, L., Bonnetain, F., Rougier, P. R., Raoul, J., Gamelin, E., Etienne, P.-L., Cadiot, G., Mitry, E., Smith, D. M., Cvitkovic, F., et al. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0104 · Cited by 87
Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors.
Perri, M., Erba, P., Volterrani, D., et al. (2008) · PubMed · Cited by 85
Neoadjuvant peptide receptor radionuclide therapy for aninoperable neuroendocrine pancreatic tumor
Kaemmerer, D., Prasad, V., Daffner, W., Hörsch, D., Klöppel, G., Hommann, M., & Baum, R. P. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5867 · Cited by 85
ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors
Kos‐Kudła, B., O’Toole, D., Falconi, M., Gross, D., Klöppel, G., Sundin, A., Ramage, J. K., Öberg, K., Wiedenmann, B., Komminoth, P., et al. (2010) · Neuroendocrinology · doi:10.1159/000287255 · Cited by 84
Self-citationLong-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours
Grozinsky‐Glasberg, S., Kaltsas, G., Gur, C., Gal, E., Thomas, D., Fichman, S., Alexandraki, K., Barak, D., Gläser, B., Shimon, I., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0420 · Cited by 79
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs
Campana, D., Nori, F., Pezzilli, R., Piscitelli, L., Santini, D., Brocchi, E., Corinaldesi, R., & Tomassetti, P. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0251 · Cited by 75
Interventional Treatment of Gastrointestinal Neuroendocrine Tumours
Ahlman, H. K., Wängberg, B., Jansson, S., Friman, S., Olausson, M., Tylén, U., & Nilsson, O. (2000) · Digestion · doi:10.1159/000051857 · Cited by 67
Liver Transplantation for Treatment of Metastatic Neuroendocrine Tumors
Ahlman, H., Friman, S., Cahlin, C., Nilsson, O., Jansson, S. K. G., Wängberg, B., & Olausson, M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.029 · Cited by 65
Brizzi, M. P., Berruti, A., Ferrero, A., Milanesi, E., Volante, M., Castiglione, F., Birocco, N., Bombaci, S., Perroni, D., Ferretti, B., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-388 · Cited by 64
Ong, G. S. Y., Henley, D., Hurley, D. M., Turner, J. H., Claringbold, P. G., & Fegan, P. G. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1010 · Cited by 62
Gurusamy, K. S., Pamecha, V., Sharma, D., & Davidson, B. R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007118.pub2 · Cited by 55
Circulating markers for endocrine tumours of the gastroenteropancreatic tract
Ardill, J. E. S. (2008) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2008.008039 · Cited by 54
Maire, F., Hammel, P. R., Kianmanesh, R., Hentic, O., Couvelard, A., Rebours, V., Zappa, M., Raymond, É., Sauvanet, A., Louvet, C., et al. (2008) · Surgery · doi:10.1016/j.surg.2008.08.007 · Cited by 49
Self-citationNeuroendocrine Liver Metastases
Reddy, S. K., & Clary, B. M. (2010) · Surgical Clinics of North America · doi:10.1016/j.suc.2010.04.016 · Cited by 38
Jeske, W., Glinicki, P., & Kapuścińska, R. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1146-5 · Cited by 27
Chandra, P., Yarandi, S., Khazai, N. B., Jacobs, S., & Umpierrez, G. E. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181ee7be2 · Cited by 23
Clinical Utility of Hybrid SPECT-CT in Endocrine Neoplasia
Patel, C. N., Chowdhury, F. U., & Scarsbrook, A. F. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.2946 · Cited by 21
Cited by
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Caplin, M. E., Pavel, M., Ćwikła, J. B., Phan, A. T., Raderer, M., Sedláčková, E., Cadiot, G., Wolin, E. M., Capdevila, J., Wall, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316158 · Cited by 1,935
Self-citationFalconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Pavel, M., O''Toole, D., Costa, F., Capdevila, J., Gross, D., Kianmanesh, R., Krenning, E., Knigge, U., Salazar, R., Pape, U.-F., et al. (2016) · Neuroendocrinology · doi:10.1159/000443167 · Cited by 1,041
Self-citationCaplin, M. E., Baudin, E., Ferolla, P., Filosso, P., Garcia-Yuste, M., Lim, E., Oberg, K., Pelosi, G., Perren, A., Rossi, R. E., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv041 · Cited by 714
Self-citationJensen, R. T., Cadiot, G., Brandi, M. L., de Herder, W. W., Kaltsas, G., Komminoth, P., Scoazec, J.-Y., Salazar, R., Sauvanet, A., & Kianmanesh, R. (2012) · Neuroendocrinology · doi:10.1159/000335591 · Cited by 622
Self-citation
Metadata
- Authors
- Pavel, M., Baudin, E., Couvelard, A., Krenning, E., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B., & Salazar, R.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2012
- Volume
- 95
- Issue
- 2
- Pages
- 157-176
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2006821285
- Cited by
- 873
- References
- 117
- FWCI
- 62.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.